Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA approval for Enjuvia NDA

May 14, 2004

Testosterone gel associated with enhanced sexual function

May 13, 2004

Evista launched in Japan

May 13, 2004

Kansas State U. researchers described inhibitors of lymphatic cholesterol absorption

May 13, 2004

Novel estrogen receptor modulators covered by Pfizer patent

May 13, 2004

Rosiglitazone effective in post-transplant diabetes

May 13, 2004

Peptimmune licenses rights to GT389-255 from Genzyme

May 12, 2004

French researchers describe imidazoline-based glucose and lipid lowering agents

May 12, 2004

Cyclic peptide with glucagon antagonist activity isolated from Streptomyces cultures

May 12, 2004

New cannabinoid CB1 antagonists/inverse agonists claimed by Pfizer

May 12, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...